Needle Free Injection System Market Scope And Analysis

Report Code : TIPRE00009273
Category : Life Sciences

Status : Published
No. of Pages : 252

Buy Now

Needle-Free Injection System Market Scope, Growth, Size and Share by 2028

Buy Now

Needle-Free Injection System Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 131.64 Million
Market Size by 2028	US$ 411.31 Million
Global CAGR (2021 - 2028)	17.7%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Type Liquid-Based Needle-Free Injectors Projectile/Depot-Based Needle-Free Injectors Powder-Based Needle Free Injectors By Product Fillable Needle-Free Injectors Prefilled Needle-Free Injectors By Technology Jet-Based Needle-Free Injectors Spring Global Needle-Free Injectors Laser-Powered Needle-Free Injectors Vibration-Based Needle-Free Injectors By Usability Disposable Needle-Free Injectors Reusable Needle-Free Injectors
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Crossject INOVIO Pharmaceuticals Zealand Pharma A S PharmaJet Portal Instruments Medical International Technologies MIT Canada Inc NuGen Medical Devices Ferring B V National Medical Products Inc

Industry Developments and Future Opportunities:

Various initiatives taken by major players operating in the global needle-free injection system market are listed below:

In November 2023, Micron Biomedical received funds to manufacture needle-free vaccines. The vaccine is painless to administer and works by applying the microarray technology to the skin and pressing a button for delivery.
In June 2022, NovaXS launched its patented ‘Telosis technology’ to administer a narrow stream of medication without a needle in 0.3 seconds for smarter health decisions.
In December 2022, Prejex Inc. announced an agreement with Polybond to manufacture needleless injections.
In November 2020, PharmaJet, a leading manufacturer of needle-free injection devices, announced a strategic partnership with Mundipharma, a global pharmaceutical company. This partnership aimed to expand the availability of PharmaJet's needle-free injection technology for administering vaccines and medications.

Competitive Landscape and Key Companies:

PharmaJet, Portal Instruments, Medical International Technology, Inc., NuGen Medical Devices, Crossject SA, Antares Pharma, 3M, Injex Pharma AG, NovaXS Biotech, INVIO Pharmaceutical Inc. are the major needle-free injection system companies. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.